Biofermin Pharmaceutical Co., Ltd. Kobe Plant FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Biofermin Pharmaceutical Co., Ltd. Kobe Plant has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Biofermin Pharmaceutical Co., Ltd. Kobe Plant" is on file.

What these totals cover: FDA records filed under the name "Biofermin Pharmaceutical Co., Ltd. Kobe Plant".

Latest inspection
Jan 25, 2019 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Biofermin Pharmaceutical Co., Ltd. Kobe Plant as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Biofermin Pharmaceutical Co., Ltd. Kobe Plant yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

1 inspection on Jan 25, 2019.

DateSiteProductClassificationFEI
Jan 25, 2019Kobe, JapanFood/CosmeticsNo Action Indicated (NAI)3013222283
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3013222283Kobe, Japan1Jan 25, 2019

Biofermin Pharmaceutical Co., Ltd. Kobe Plant and the FDA: common questions

Has Biofermin Pharmaceutical Co., Ltd. Kobe Plant received an FDA warning letter?

No FDA warning letter addressed to the name "Biofermin Pharmaceutical Co., Ltd. Kobe Plant" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Biofermin Pharmaceutical Co., Ltd. Kobe Plant received an FDA Form 483?

FDA has not published a Form 483 for "Biofermin Pharmaceutical Co., Ltd. Kobe Plant" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Biofermin Pharmaceutical Co., Ltd. Kobe Plant?

The most recent FDA inspection on file ended Jan 25, 2019 at Kobe, Japan and was classified NAI. FDA has 1 inspection of Biofermin Pharmaceutical Co., Ltd. Kobe Plant on file.

Need more than this page shows? Ask about Biofermin Pharmaceutical Co., Ltd. Kobe Plant in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.